Cargando…
Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study
OBJECTIVE: Patients with chronic hepatitis B (CHB) are reported to exhibit higher risk of subsequent hepatocellular carcinoma (HCC). However, it remains unclear if Chinese herbal medicine (CHM), an important category of traditional Chinese medicine (TCM), may lower HCC risk in this population. So th...
Autores principales: | Tsai, Tzung-Yi, Livneh, Hanoch, Hung, Tsung-Hsing, Lin, I -Hsin, Lu, Ming-Chi, Yeh, Chia-Chou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278254/ https://www.ncbi.nlm.nih.gov/pubmed/28122837 http://dx.doi.org/10.1136/bmjopen-2016-014571 |
Ejemplares similares
-
Chinese herbal medicine therapy and the risk of mortality for chronic hepatitis B patients with concurrent liver cirrhosis: a nationwide population-based cohort study
por: Tsai, Tzung-Yi, et al.
Publicado: (2018) -
The Prescription of Chinese Herbal Medicine and Risk of Endometriosis in Women with Rheumatoid Arthritis: A Population-Based Cohort Study
por: Chen, Chia-Jung, et al.
Publicado: (2022) -
Chinese Herbal Medicine to Reduce Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients: Evidence From Population-Based Health Claims
por: Li, Hsin-Hua, et al.
Publicado: (2021) -
Association of traditional Chinese medicine therapy and the risk of dementia in patients with hypertension: a nationwide population-based cohort study
por: Chen, Kuen-Hau, et al.
Publicado: (2017) -
Reduced Stroke Risk among Patients with Atrial Fibrillation Receiving Chinese Herbal Medicines Treatment: Analysis of Domestic Data in Taiwan
por: Zheng, Li-Cheng, et al.
Publicado: (2020)